Consulting
Biomarkers & Precision Oncology Consulting
Molecular biomarkers are most useful when the assay, tissue context and clinical question are considered together. I help teams evaluate evidence and interpret complex findings.
Biomarker strategy and interpretation
- Predictive and prognostic molecular biomarkers
- Genomic profiling and interpretation of complex tumour findings
- Integration of molecular and immunohistochemical results
- Molecular classification, including methylation profiling
- Biomarker development and translational validation
- Scientific input on companion diagnostic strategies
Connecting pathology and oncology
Scientific interpretation requires attention to tumour type, specimen quality, assay limitations and the strength of the supporting evidence. I can help clarify the relevance of a finding and identify where further evidence is needed.
Support for laboratories and industry
Projects may include a review of biomarker evidence, advice on assay selection, an interpretation framework for a study or expert input into diagnostic development.
Consulting supports your diagnostic and scientific team. Patient-specific decisions remain with the responsible clinical professionals.
Let’s discuss your project.
Tell me what you are working on and where you need support.